Mucosal IgE to Improve Diagnosis of Food Allergy and Food Hypersensitivity
Improving the Diagnosis of Food Allergy and Food Intolerance by Determining Mucosal IgE and Inflammatory Markers and Validating With Intestinal in Vitro Organoids
1 other identifier
interventional
115
1 country
1
Brief Summary
Aim of the study is to improve the diagnosis of food allergy and hypersensitivity. Intestinal homogenates will be used to determine total IgE, specific IgE, tryptase, histamine and inflammation parameters (IFNgamma, TNFalpha). These data will be correlated with serum values and disease status. In addition, organoids from duodenal tissue will be isolated and cultured in vitro and stimulated with the major food allergens. The gene and protein expression will be checked to identify relevant biomarkers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2022
CompletedFirst Submitted
Initial submission to the registry
February 18, 2022
CompletedFirst Posted
Study publicly available on registry
March 2, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2025
CompletedJuly 5, 2024
July 1, 2024
3 years
February 18, 2022
July 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Determination of mucosal IgE to identify patients with gastrointestinal food allergy
Homogenates of mucosal biopsies will be checked for IgE levels
3 years
Secondary Outcomes (2)
Identification of patients with food hypersensitivity
3 years
Correlation of mucosal IgE and inflammatory parameters with data from organoids
3 years
Study Arms (2)
patients with food hypersensitivity
EXPERIMENTALhealthy controls
EXPERIMENTALInterventions
1. Biopsies are homogenised in buffer and used for the determination of mucosal IgE and inflammatory parameters. 2. Biopsies are used to isolate organoids, stimulate them with blood cells and food antigens and to study gene and protein expression.
Eligibility Criteria
You may qualify if:
- informed consent
- patients with suspected food allergy or hypersensitivity
You may not qualify if:
- pregnant person
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Medicine 1, Hector Center for Nutrition, Exercise and Sports, Friedrich-Alexander-University Erlangen-Nuremberg
Erlangen, 91052, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor Dr.
Study Record Dates
First Submitted
February 18, 2022
First Posted
March 2, 2022
Study Start
February 1, 2022
Primary Completion
January 31, 2025
Study Completion
January 31, 2025
Last Updated
July 5, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share